Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, ... BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology. Mehr anzeigen
RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors...
RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Health Services Executive (HSE) in Ireland has recommended...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.305 | -3.95077720207 | 7.72 | 7.72 | 7.1501 | 2024474 | 7.42701765 | CS |
| 4 | -0.045 | -0.603217158177 | 7.46 | 8.16 | 7.11 | 1842781 | 7.51584294 | CS |
| 12 | -0.225 | -2.94502617801 | 7.64 | 8.44 | 6.845 | 1979460 | 7.5567039 | CS |
| 26 | 1.435 | 23.9966555184 | 5.98 | 8.88 | 5.92 | 2237605 | 7.43517979 | CS |
| 52 | 1.445 | 24.2043551089 | 5.97 | 8.88 | 4.03 | 2813613 | 6.36094164 | CS |
| 156 | -5.425 | -42.2507788162 | 12.84 | 19.99 | 4.03 | 3131631 | 9.23362772 | CS |
| 260 | 4.205 | 130.996884735 | 3.21 | 19.99 | 1.58 | 4151468 | 8.12143791 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
